Bayer Announces Market Withdrawal of Baycol

by Mario Lozano on October 24, 2002

in Baycol

Bayer has discontinued the marketing and distribution of all dosage strengths of Baycol. Patients who are currently taking Baycol should have their Baycol discontinued and be switched to an alternative therapy by their physicians.

It is important to you forward any adverse event information associated with the use of Baycol to Bayer Corporation at 1-800-288-8371. You can also report the information directly to the FDA via the MedWatch system at 1-800-FDA-1088, by mail (using a postage paid form), or the Internet at www.fda.gov/medwatch.

If you have further questions regarding this action on Baycol, please contact Bayer customer service at 1-800-758-9794.

(via FDA – MEDWATCH)

Comments on this entry are closed.

Previous post:

Next post: